Powered by

G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August

Aug 06, 2019 - GlobeNewswire

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will participate in two investor conferences in August 2019.

The company will meet with investors at the 2019 BTIG Biotechnology Conference on Monday, August 12 at the St. Regis New York in New York, NY.Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the 2019 Wedbush PacGrow Healthcar...